Hao Sun

ORCID：0000-0002-8480-9645

发表论文 114 篇 · 总被引 1818 次 · h-index 22

代表论文

• A Novel In Vitro Permeability and Efflux Classification System for Proteolysis Targeting Chimeras (PROTACs) (2026 · Drug Metabolism and Disposition)
• Supplementary Table 2 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47 (2026)
• Supplementary Figure 16 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47 (2026)
• Supplementary Figure 6 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47 (2026)
• Supplementary Table 1 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47 (2026)
• Supplementary Figure 11 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47 (2026)